These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 17854044

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cadaveric renal transplantation in hepatitis B antigen-positive recipients using hepatitis B antigen-positive donor organs with lamivudine treatment.
    Kim JA, Huh W, Lee KW, Kim SJ, Kim YG, Kim DJ, Joh JW, Oh HY.
    Transplant Proc; 2004 Jun; 36(5):1434-7. PubMed ID: 15251352
    [Abstract] [Full Text] [Related]

  • 5. Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience.
    Murakami R, Amada N, Sato T, Orii T, Kikuchi H, Haga I, Ohashi Y, Okazaki H.
    Clin Transplant; 2006 Jun; 20(3):351-8. PubMed ID: 16824154
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L, Vargas V, Rodríguez F, Allende H, Buti M, Sánchez-Avila JF, Jardí R, Margarit C, Pumarola T, Esteban R, Guardia J.
    Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
    [Abstract] [Full Text] [Related]

  • 8. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
    Gwak GY, Huh W, Lee DH, Choi MS, Lee JH, Koh KC, Kim SJ, Joh JW, Oh HY.
    Transplant Proc; 2007 Dec; 39(10):3121-6. PubMed ID: 18089336
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term outcome of renal transplant recipients with chronic hepatitis B infection-impact of antiviral treatments.
    Yap DY, Tang CS, Yung S, Choy BY, Yuen MF, Chan TM.
    Transplantation; 2010 Aug 15; 90(3):325-30. PubMed ID: 20562676
    [Abstract] [Full Text] [Related]

  • 13. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
    Sumethkul V, Ingsathit A, Jirasiritham S.
    Transplant Proc; 2009 Aug 15; 41(1):213-5. PubMed ID: 19249516
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Successful treatment of hepatitis B virus infection with Lamivudine after heart transplantation.
    Wang SS, Chou NK, Chi NH, Hsu RB, Huang SC, Chen YS, Yu HY, Tsao CI, Ko WJ, Lai MY, Chu SH.
    Transplant Proc; 2006 Sep 15; 38(7):2138-40. PubMed ID: 16980024
    [Abstract] [Full Text] [Related]

  • 16. Changes in serological markers of hepatitis B virus after renal transplantation.
    Urbini Dos Santos C, Sevá-Pereira T, Alves-Filho G, Lorena SL, Soares EC, Mazzali M.
    Transplant Proc; 2008 Apr 15; 40(3):749-51. PubMed ID: 18455006
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
    Huang H, Cai Q, Lin T, Lin X, Liu Y, Gao Y, Peng R.
    Expert Opin Pharmacother; 2009 Oct 15; 10(15):2399-406. PubMed ID: 19761353
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.